Australia’s premiere event for technology investment TechKnow Invest Roadshow Series 9 is set to harness the power of one of the world’s greatest financial hubs, establishing a partnership with Invest Hong Kong (InvestHK).
InvestHK is the investment arm of the Hong Kong Special Administrative Region responsible for attracting Foreign Direct Investment and supporting overseas and mainland China businesses to set up and expand in Hong Kong.
The partnership between TechKnow and InvestHK will see the government body bring its fundraising expertise and powerful connections to the Sydney and Melbourne-based events, held on the 22nd and 24th October respectively.
With a particular interest in medtech and edtech, InvestHK will participate in one-on-one meetings at TechKnow Series 9, educating companies about the different avenues available to access Hong Kong-based funding.
Commenting on the partnership, InvestHK Deputy Head of Australia & New Zealand Ms Yin Robards said:
“The upcoming TechKnow event presents a fantastic opportunity, providing InvestHK with immediate access to some of Australia’s top technology companies – and in turn those companies are able to better understand our role and connections in Hong Kong.
“InvestHK has global reach with representatives in Asia Pacific, Europe, Middle East, North America and South America, and has been based in Australia and New Zealand for more than 20 years.”
Vertical Events Business Development Manager Jaxon Crabb added:
“The partnership with InvestHK only further enhances the quality of investors, companies and business connections in attendance at TechKnow.
“Registrations continue to be very healthy for Series 9 as more groups across the globe continue to deepen their involvement in Australian technology.”
TechKnow Invest Series 9 is set to attract a large audience with +750 investors anticipated across the two days.
The event has already secured keynote presentations from some of the most prospective technology groups, from start-ups to large ASX-listed companies.
Series 9 will include presentations from companies including revolutionary IVF treatment innovator Memphasys (ASX:MEM), smartphone-based pain assessment tool PainChek (ASX:PCK) and NeuroScientific Biopharmaceuticals (ASX:NSB), which is developing pharmaceutical solutions for neurological disorders.
Spaces are filling quickly, so to secure your place at the TechKnow Invest Roadshow, visit:
